Is Acme Resources overvalued or undervalued?
As of October 14, 2025, Acme Resources is overvalued with a PE ratio of 26.69 and a low ROE of 2.71%, indicating high risk despite a strong historical stock return, while its recent performance has declined by 18.35% compared to the Sensex's gain of 4.98%.
As of 14 October 2025, Acme Resources has moved from an expensive to a very expensive valuation grade. The company is currently overvalued, with a PE ratio of 26.69, an EV to EBIT of 21.96, and a ROE of 2.71%. In comparison to peers, Bajaj Finance has a significantly higher PE ratio of 36.37, while Life Insurance stands out with a much lower PE ratio of 11.7, indicating that Acme Resources is priced at a premium relative to some competitors in the Non Banking Financial Company (NBFC) sector.The valuation metrics suggest that Acme Resources is not only overvalued but also carries a high risk given its low ROCE of 3.40%. Despite a strong 5-year stock return of 307.6%, the recent year-to-date performance shows a decline of 18.35%, contrasting sharply with the Sensex's gain of 4.98%. This further reinforces the notion that the stock may be overpriced in the current market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
